What will be counted as a moral issue or difficulty, in the sense requiring moral agents' recognition, will again vary by moral theory.
To goal is to identify opportunities to training, promotions and change-agent recognition.
The host immune response may also be problematic: with viral gene transfer agents, recognition of viral coat proteins and the production of neutralizing antibodies leads to problems with re-administration.
An argument from indiscernible persons and imposters provide a rationale for thinking that agent-recognition cannot secure the discriminative identification of indiscernible agents (Bullot in press).
According to the psycho-historical theory, agent-identifications and predictions derived from either agent-recognition or heuristics can be outperformed by methods and techniques for tracking that benefit from scientific theories of the target's agency-making mechanisms.
Games like Puzzle Agent deserve recognition for stepping outside the box and delivering an engrossing experience.
It follows that a rational agent's recognition of a reason entails the presence of a relevant desire.
These are theoretical tasks which require the design of a data structure, a database schema, an algorithm, and a functional flow connecting the agent's recognition and action.
For if the practicality requirement on moral judgement is correct then the non-naturalist needs to provide some account of why an agent's recognition that one of the actions available to her has the non-natural property of rightness is such that her recognition of this fact rationally requires that she be motivated to perform the action.
This paper presents the novel theory for performing multi-agent activity recognition without requiring large training corpora.
In patients with high ferritin levels (> 2000 ng mL−1), iron chelating drugs can also be given, together with other specific drugs like cytokines (erythropoietin ± G-CSF), chemotherapy, or immunomodulating agents, with recognition of potentially harmful drug combination effects (e.g. effects of deferasirox and cyclosporine A, both of which may impair kidney function).
